The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al
- PMID: 32340978
- DOI: 10.1136/annrheumdis-2020-217545
The conundrum of COVID-19 treatment targets: the close correlation with rheumatology. Response to: 'Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology pracitioners from India' by Gupta et al and 'Antirheumatic agents in covid-19: is IL-6 the right target?' by Capeechi et al
Keywords: arthritis, rheumatoid; immune system diseases; inflammation.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Antirheumatic agents in covid-19: is IL-6 the right target?Ann Rheum Dis. 2021 Jan;80(1):e2. doi: 10.1136/annrheumdis-2020-217523. Epub 2020 Apr 16. Ann Rheum Dis. 2021. PMID: 32299796 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources